<?xml version="1.0" encoding="UTF-8"?>
<ref id="ajh25238-bib-0002">
 <label>2</label>
 <mixed-citation publication-type="journal" id="ajh25238-cit-0002">
  <string-name>
   <surname>Stone</surname>
   <given-names>RM</given-names>
  </string-name>, 
  <string-name>
   <surname>Mazzola</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Neuberg</surname>
   <given-names>D</given-names>
  </string-name>, et al. 
  <article-title>Phase III open‐label randomized study of cytarabine in combination with amonafide 
   <sc>l</sc>‐malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia
  </article-title>. 
  <source xml:lang="en">J Clin Oncol</source>. 
  <year>2015</year>;
  <volume>33</volume>:
  <fpage>1252</fpage>‐
  <lpage>1257</lpage>.
  <pub-id pub-id-type="pmid">25732165</pub-id>
 </mixed-citation>
</ref>
